Scott Dalgleish - 21 Mar 2022 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Scott Dalgleish
Issuer symbol
TOI
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
29 Mar 2022, 20:10:43 UTC
Date Of Original Report
23 Mar 2022
Previous filing
16 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Stock Option (right to buy) Award $0 +162,891 $0.000000 162,891 21 Mar 2022 Common stock 162,891 $7.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 1/3rd of the options granted on the second anniversary of November 12, 2021 (the "Vesting Commencement Date"), with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

Remarks:

This amendment is filed to correct the number of options granted due to an administrative error in applying the grant amount calculations.